Literature DB >> 10785223

Serum levels of inhibins are differentially altered in patients with polycystic ovary syndrome: effects of being overweight and relevance to hyperandrogenism.

P Pigny1, C Cortet-Rudelli, C Decanter, D Deroubaix, B Soudan, A Duhamel, D Dewailly.   

Abstract

OBJECTIVE: To explore the abnormalities of serum inhibin isoform concentrations in a large group of patients with polycystic ovary syndrome (PCOS) and to evaluate the influence of body mass index (BMI), age, LH, and androgens on serum inhibin levels.
DESIGN: Prospective study.
SETTING: Reproductive endocrinology unit of an academic medical center. PATIENT(S): Forty-one women with PCOS were compared with 24 healthy women. INTERVENTION(S): Blood sampling was performed in the early follicular phase in patients and in control women. MAIN OUTCOME MEASURE(S): Serum levels of inhibin A, inhibin B, alpha-inhibin, pro-alphaC (alpha-inhibin precursor proteins), LH, FSH, E(2), T, and androstenedione (A) were assessed in all subjects. RESULT(S): Serum alpha-inhibin levels together with LH, T, and A levels were significantly increased in women with PCOS. Serum inhibin A levels were lower in patients with PCOS than controls (median +/- SD: 7.35 +/- 2.9 vs. 9.4 +/- 4.7 pg/mL), pro-alphaC levels were higher (264 +/- 136.7 vs. 127 +/- 81.5 pg/mL), and inhibin B levels did not differ between the groups (110.5 +/- 51.5 vs. 108 +/- 47.5 pg/mL). Simple regression analysis showed that inhibin A and B levels were negatively correlated with BMI in patients with PCOS (r = -0.43 and r27 kg/m(2)) displayed significantly lower inhibin A and inhibin B levels and a higher pro-alphaC-inhibin A ratio than nonobese patients with PCOS (BMI </=27 kg/m(2)). In this last subgroup, the mean inhibin B level was significantly higher than in controls (median +/- SD: 144 +/- 53.5 vs. 108 +/- 47.5 pg/mL). Partial regression analysis, after controlling for age and BMI, demonstrated that in patients with PCOS, pro-alphaC levels were positively and independently correlated with LH and A levels. CONCLUSION(S): Among women with PCOS, the trend toward an excess serum inhibin B level is observed exclusively in nonobese patients. The higher pro-alphaC levels and the lower inhibin A levels might reflect a defect in the processing of inhibins specific to polycystic ovaries. In addition, our data suggest that pro-alphaC originates from the theca-interstitial cells and could participate in control of the androgen production by these cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10785223     DOI: 10.1016/s0015-0282(00)00421-0

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  9 in total

1.  Luteal-phase inhibin A and follicular-phase inhibin B levels are not characteristic of patients with an elevated LH-to-FSH ratio.

Authors:  Erik E Hauzman; Péter Fancsovits; Akos Murber; Thomas Rabe; Thomas Strowitzki; Zoltán Papp; János Urbancsek
Journal:  J Assist Reprod Genet       Date:  2006-03       Impact factor: 3.412

Review 2.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

3.  Relating smoking, obesity, insulin resistance, and ovarian biomarker changes to the final menstrual period.

Authors:  MaryFran R Sowers; Daniel McConnell; Matheos Yosef; Mary L Jannausch; Sioban D Harlow; John F Randolph
Journal:  Ann N Y Acad Sci       Date:  2010-08       Impact factor: 5.691

4.  Cryptotanshinone reverses reproductive disturbances in rats with dehydroepiandrosterone-induced polycystic ovary syndrome.

Authors:  Yanqiu Xia; Pei Zhao; Hongli Huang; Yuan Xie; Rong Lu; Li Dong
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

5.  Diminished paternity and gonadal function with increasing obesity in men.

Authors:  Eric M Pauli; Richard S Legro; Laurence M Demers; Allen R Kunselman; William C Dodson; Peter A Lee
Journal:  Fertil Steril       Date:  2008-02-21       Impact factor: 7.329

6.  Decreased inhibin B responses following recombinant human chorionic gonadotropin administration in normal women and women with polycystic ovary syndrome.

Authors:  Rana F Shayya; Marcus A Rosencrantz; Sandy S Chuan; Heidi Cook-Andersen; William E Roudebush; H Irene Su; Shunichi Shimasaki; R Jeffrey Chang
Journal:  Fertil Steril       Date:  2013-11-01       Impact factor: 7.329

7.  Inhibin secretion in women with the polycystic ovary syndrome before and after treatment with progesterone.

Authors:  Konstantinos Dafopoulos; Christos Venetis; Christina I Messini; Spyros Pournaras; George Anifandis; Antonios Garas; Ioannis E Messinis
Journal:  Reprod Biol Endocrinol       Date:  2011-04-29       Impact factor: 5.211

8.  First intention IVF protocol for polycystic ovaries: does oral contraceptive pill pretreatment influence COH outcome?

Authors:  Christine Decanter; Geoffroy Robin; Patricia Thomas; Maryse Leroy; Catherine Lefebvre; Benoit Soudan; Valerie Lefebvre-Khalil; Brigitte Leroy-Martin; Didier Dewailly
Journal:  Reprod Biol Endocrinol       Date:  2013-06-19       Impact factor: 5.211

9.  Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results.

Authors:  Aylin Yetim; Çağcıl Yetim; Firdevs Baş; Oğuz Bülent Erol; Gülnaz Çığ; Ahmet Uçar; Feyza Darendeliler
Journal:  J Clin Res Pediatr Endocrinol       Date:  2016-04-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.